These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 8832150)

  • 1. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.
    Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A
    Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verocytotoxin-producing Escherichia coli infection in family members of children with hemolytic uremic syndrome.
    Rivas M; Voyer LE; Tous M; De Mena MF; Leardini N; Wainsztein R; Callejo R; Quadri B; Corti S; Prado V
    Medicina (B Aires); 1996; 56(2):119-25. PubMed ID: 8935562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.
    Caprioli A; Luzzi I; Rosmini F; Pasquini P; Cirrincione R; Gianviti A; Matteucci MC; Rizzoni G
    J Infect Dis; 1992 Jul; 166(1):154-8. PubMed ID: 1607689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli.
    Caprioli A; Luzzi I; Rosmini F; Resti C; Edefonti A; Perfumo F; Farina C; Goglio A; Gianviti A; Rizzoni G
    J Infect Dis; 1994 Jan; 169(1):208-11. PubMed ID: 8277184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
    Karmali MA; Petric M; Lim C; Fleming PC; Arbus GS; Lior H
    J Infect Dis; 1985 May; 151(5):775-82. PubMed ID: 3886804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological aspects of infection with verotoxin-producing E. coli strains in children with the hemolytic-uremic syndrome].
    Bielaszewská M; Janda J
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):237-44. PubMed ID: 2676199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome.
    Yamada S; Kai A; Kudoh Y
    J Clin Microbiol; 1994 Apr; 32(4):955-9. PubMed ID: 8027349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Serological Tests Against Verotoxigenic Escherichia coli in Hemolytic Uremic Syndrome in Children.
    Leszczyńska B; Ziółkowska H; Podsiadły E; Szych J; Rastawicki W; Demkow U; Roszkowska-Blaim M
    Adv Clin Exp Med; 2015; 24(6):1031-6. PubMed ID: 26771976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infections with verocytotoxin-producing Escherichia coli and hemolytic-uremic syndrome].
    van de Kar NC; Heuvelink AE; de Boer E; Monnens LA
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):134-7. PubMed ID: 8618631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vero cytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome.
    te Loo DM; Heuvelink AE; de Boer E; Nauta J; van der Walle J; Schröder C; van Hinsbergh VW; Chart H; van de Kar NC; van den Heuvel LP
    J Infect Dis; 2001 Aug; 184(4):446-50. PubMed ID: 11471102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.
    Yamada S; Matsushita S; Kai A; Sasaki M; Tsuji A; Kanemitsu T; Yamashita N; Anzai E; Kudoh Y
    Microbiol Immunol; 1993; 37(2):111-8. PubMed ID: 8502176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes.
    Scotland SM; Rowe B; Smith HR; Willshaw GA; Gross RJ
    J Med Microbiol; 1988 Apr; 25(4):237-43. PubMed ID: 3282072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.
    Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE
    Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolytic-uremic syndrome--microbiological study].
    Lhotová H; Bielaszewská M; Kopalová E; Stolbová M
    Cesk Epidemiol Mikrobiol Imunol; 1990 Jan; 39(1):13-20. PubMed ID: 2139808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.
    Chart H; Smith HR; Scotland SM; Rowe B; Milford DV; Taylor CM
    Lancet; 1991 Jan; 337(8734):138-40. PubMed ID: 1670788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
    Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
    Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.